Sfoglia per Rivista
Safety, Tolerability, and Management of Toxic Effects of Phosphatidylinositol 3-Kinase Inhibitor Treatment in Patients with Cancer: A Review
2019 A. Esposito, G. Viale, G. Curigliano
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination with Nivolumab for Patients with Advanced Solid Tumors : A Phase 1/2a Dose-Escalation and Cohort-Expansion Clinical Trial
2020 K.M. Heinhuis, M. Carlino, M. Joerger, M. Di Nicola, T. Meniawy, S. Rottey, V. Moreno, A. Gazzah, J.-. Delord, L. Paz-Ares, C. Britschgi, R.J. Schilder, K. O'Byrne, G. Curigliano, E. Romano, P. Patah, R. Wang, Y. Liu, G. Bajaj, L.L. Siu
Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
---|---|---|---|---|---|
Safety, Tolerability, and Management of Toxic Effects of Phosphatidylinositol 3-Kinase Inhibitor Treatment in Patients with Cancer: A Review | 2019 | Curigliano G. + | Article (author) | - | |
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination with Nivolumab for Patients with Advanced Solid Tumors : A Phase 1/2a Dose-Escalation and Cohort-Expansion Clinical Trial | 2020 | Curigliano G. + | Article (author) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile